{"DataElement":{"publicId":"5326898","version":"1","preferredName":"Gynecologic Ovarian Tumor Federation of Gynecology and Obstetrics (FIGO) 2014 Stage","preferredDefinition":"Anatomic extent of the primary carcinoma of the ovary based on surgical pathologic examination based on the FIGO 2014 ovarian cancer staging.","longName":"5326530v1.0:5326876v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"5326530","version":"1","preferredName":"Gynecologic Neoplasm Ovary Federation of Gynecology and Obstetrics Stage","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._One of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova._An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies._Any distinct time period in a sequence of events.","longName":"2206690v1.0:5326528v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2206690","version":"1","preferredName":"Gynecologic Neoplasm","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C28016:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gynecologic","conceptCode":"C28016","definition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0016-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5326528","version":"1","preferredName":"Ovary Federation of Gynecology and Obstetrics Stage","preferredDefinition":"One of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova.:An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.:Any distinct time period in a sequence of events.","longName":"C12404:C89808:C48308","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovary","conceptCode":"C12404","definition":"One of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Federation of Gynecology and Obstetrics","conceptCode":"C89808","definition":"An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage","conceptCode":"C48308","definition":"Any distinct time period in a sequence of events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36569E70-87C6-BE91-E050-BB89AD436538","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"36569E70-87D7-BE91-E050-BB89AD436538","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBREXT","dateModified":"2016-09-15","changeDescription":"Created for Duke study in Rave. mc 6/28/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5326876","version":"1","preferredName":"FIGO 2014 Ovarian Cancer Stage","preferredDefinition":"A category of staging terms for ovarian cancer according to the International Federation of Gynecology and Obstetrics (FIGO), 2014. AJCC ovarian cancer stage terms from the 6th and 7th editions that are synonymous to the FIGO ovarian cancer staging classification of 2014 are included as preferred terms_The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"5326876v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"9","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IVB","valueDescription":"FIGO Stage IVB Ovarian Cancer","ValueMeaning":{"publicId":"5326879","version":"1","preferredName":"FIGO Stage IVB Ovarian Cancer","longName":"5326879","preferredDefinition":"Ovarian cancer with hepatic and/or splenic parenchymal metastasis, metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside of the abdominal cavity). (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IVB Ovarian Cancer","conceptCode":"C128095","definition":"Ovarian cancer with hepatic and/or splenic parenchymal metastasis, metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside of the abdominal cavity). (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-59ED-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5A06-83B5-E050-BB89AD435454","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IVA","valueDescription":"FIGO Stage IVA Ovarian Cancer","ValueMeaning":{"publicId":"5326880","version":"1","preferredName":"FIGO Stage IVA Ovarian Cancer","longName":"5326880","preferredDefinition":"Ovarian cancer with pleural effusion with positive cytology. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IVA Ovarian Cancer","conceptCode":"C128094","definition":"Ovarian cancer with pleural effusion with positive cytology. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5A12-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5A2B-83B5-E050-BB89AD435454","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IIIA2","valueDescription":"FIGO Stage IIIA2 Ovarian Cancer","ValueMeaning":{"publicId":"5326881","version":"1","preferredName":"FIGO Stage IIIA2 Ovarian Cancer","longName":"5326881","preferredDefinition":"Ovarian cancer with microscopic, extrapelvic (above the brim) peritoneal involvement ± positive retroperitoneal lymph nodes. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIA2 Ovarian Cancer","conceptCode":"C128091","definition":"Ovarian cancer with microscopic, extrapelvic (above the brim) peritoneal involvement +/- positive retroperitoneal lymph nodes. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5A37-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5A50-83B5-E050-BB89AD435454","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IIIA1(ii)","valueDescription":"FIGO Stage IIIA1(ii) Ovarian Cancer","ValueMeaning":{"publicId":"5326882","version":"1","preferredName":"FIGO Stage IIIA1(ii) Ovarian Cancer","longName":"5326882","preferredDefinition":"Ovarian cancer with positive retroperitoneal lymph nodes only. Metastasis greater than 10 mm. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIA1(ii) Ovarian Cancer","conceptCode":"C128090","definition":"Ovarian cancer with positive retroperitoneal lymph nodes only. Metastasis greater than 10 mm. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5A5C-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5A75-83B5-E050-BB89AD435454","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IIIA1(i)","valueDescription":"FIGO Stage IIIA1(i) Ovarian Cancer","ValueMeaning":{"publicId":"5326883","version":"1","preferredName":"FIGO Stage IIIA1(i) Ovarian Cancer","longName":"5326883","preferredDefinition":"Ovarian cancer with positive retroperitoneal lymph nodes only. Metastasis equal or less than 10 mm. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIA1(i) Ovarian Cancer","conceptCode":"C128089","definition":"Ovarian cancer with positive retroperitoneal lymph nodes only. Metastasis equal or less than 10 mm. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5A81-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5A9A-83B5-E050-BB89AD435454","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IIIA1","valueDescription":"FIGO Stage IIIA1 Ovarian Cancer","ValueMeaning":{"publicId":"5326884","version":"1","preferredName":"FIGO Stage IIIA1 Ovarian Cancer","longName":"5326884","preferredDefinition":"Ovarian cancer with positive retroperitoneal lymph nodes only. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIA1 Ovarian Cancer","conceptCode":"C128088","definition":"Ovarian cancer with positive retroperitoneal lymph nodes only. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5AA6-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5ABF-83B5-E050-BB89AD435454","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IC3","valueDescription":"FIGO Stage IC3 Ovarian Cancer","ValueMeaning":{"publicId":"5326885","version":"1","preferredName":"FIGO Stage IC3 Ovarian Cancer","longName":"5326885","preferredDefinition":"Stage IC ovarian cancer with malignant cells in the ascites or peritoneal washings. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IC3 Ovarian Cancer","conceptCode":"C128084","definition":"Stage IC ovarian cancer with malignant cells in the ascites or peritoneal washings. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5ACB-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5AE4-83B5-E050-BB89AD435454","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IC2","valueDescription":"FIGO Stage IC2 Ovarian Cancer","ValueMeaning":{"publicId":"5326886","version":"1","preferredName":"FIGO Stage IC2 Ovarian Cancer","longName":"5326886","preferredDefinition":"Stage IC ovarian cancer with capsule rupture before surgery or tumor on ovarian surface. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IC2 Ovarian Cancer","conceptCode":"C128083","definition":"Stage IC ovarian cancer with capsule rupture before surgery or tumor on ovarian surface. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5AF0-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5B09-83B5-E050-BB89AD435454","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IC1","valueDescription":"FIGO Stage IC1 Ovarian Cancer","ValueMeaning":{"publicId":"5326887","version":"1","preferredName":"FIGO Stage IC1 Ovarian Cancer","longName":"5326887","preferredDefinition":"Stage IC ovarian cancer with surgical spill. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IC1 Ovarian Cancer","conceptCode":"C128082","definition":"Stage IC ovarian cancer with surgical spill. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5B15-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5B2E-83B5-E050-BB89AD435454","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"I","valueDescription":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1 TNM Finding v7","ValueMeaning":{"publicId":"3436757","version":"1","preferredName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1 TNM Finding v7","longName":"3436757","preferredDefinition":"Ovarian cancer limited to ovaries (one or both). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1 TNM Finding v7","conceptCode":"C89642","definition":"Ovarian cancer limited to ovaries (one or both). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD7F8235-4782-F2A1-E040-BB89AD436635","latestVersionIndicator":"Yes","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5B38-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IA","valueDescription":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1a TNM Finding v7","ValueMeaning":{"publicId":"3436759","version":"1","preferredName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1a TNM Finding v7","longName":"3436759","preferredDefinition":"Ovarian cancer limited to one ovary; capsule intact, no tumor on ovarian surface.  No malignant cells in ascites or peritoneal washings.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1a TNM Finding v7","conceptCode":"C89643","definition":"Ovarian cancer limited to one ovary; capsule intact, no tumor on ovarian surface.  No malignant cells in ascites or peritoneal washings.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD7F8235-47A8-F2A1-E040-BB89AD436635","latestVersionIndicator":"Yes","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5B42-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IB","valueDescription":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1b TNM Finding v7","ValueMeaning":{"publicId":"3436761","version":"1","preferredName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1b TNM Finding v7","longName":"3436761","preferredDefinition":"Ovarian cancer limited to both ovaries; capsule intact, no tumor on ovarian surface.  No malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1b TNM Finding v7","conceptCode":"C89644","definition":"Ovarian cancer limited to both ovaries; capsule intact, no tumor on ovarian surface.  No malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD7F8235-47CE-F2A1-E040-BB89AD436635","latestVersionIndicator":"Yes","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5B4C-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IC","valueDescription":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1c TNM Finding v7","ValueMeaning":{"publicId":"3436763","version":"1","preferredName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1c TNM Finding v7","longName":"3436763","preferredDefinition":"Ovarian cancer or primary peritoneal carcinoma limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT1c TNM Finding v7","conceptCode":"C89645","definition":"Ovarian cancer or primary peritoneal carcinoma limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD7F8235-47F4-F2A1-E040-BB89AD436635","latestVersionIndicator":"Yes","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5B56-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"II","valueDescription":"FIGO Stage II Ovarian Cancer","ValueMeaning":{"publicId":"5326888","version":"1","preferredName":"FIGO Stage II Ovarian Cancer","longName":"5326888","preferredDefinition":"Ovarian cancer involving one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage II Ovarian Cancer","conceptCode":"C128085","definition":"Ovarian cancer involving one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5B62-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5B7B-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Ovarian Cancer and Primary Peritoneal Carcinoma pT2a TNM Finding v7","ValueMeaning":{"publicId":"3436767","version":"1","preferredName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT2a TNM Finding v7","longName":"3436767","preferredDefinition":"Ovarian cancer or primary peritoneal carcinoma with extension and/or implants on uterus and/or tube(s).  No malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT2a TNM Finding v7","conceptCode":"C89647","definition":"Ovarian cancer or primary peritoneal carcinoma with extension and/or implants on uterus and/or tube(s).  No malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD7F8235-4840-F2A1-E040-BB89AD436635","latestVersionIndicator":"Yes","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5B85-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Ovarian Cancer and Primary Peritoneal Carcinoma pT2b TNM Finding v7","ValueMeaning":{"publicId":"3436769","version":"1","preferredName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT2b TNM Finding v7","longName":"3436769","preferredDefinition":"Ovarian cancer or primary peritoneal carcinoma with extension to and/or implants on other pelvic tissues.  No malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Cancer and Primary Peritoneal Carcinoma pT2b TNM Finding v7","conceptCode":"C89648","definition":"Ovarian cancer or primary peritoneal carcinoma with extension to and/or implants on other pelvic tissues.  No malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD7F8235-4866-F2A1-E040-BB89AD436635","latestVersionIndicator":"Yes","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5B8F-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"III","valueDescription":"FIGO Stage III Ovarian Cancer","ValueMeaning":{"publicId":"5326889","version":"1","preferredName":"FIGO Stage III Ovarian Cancer","longName":"5326889","preferredDefinition":"Ovarian cancer involving 1 or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage III Ovarian Cancer","conceptCode":"C128086","definition":"Ovarian cancer involving 1 or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5BA5-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5BBE-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"FIGO Stage IIIA Ovarian Cancer","ValueMeaning":{"publicId":"5326890","version":"1","preferredName":"FIGO Stage IIIA Ovarian Cancer","longName":"5326890","preferredDefinition":"Ovarian cancer with positive retroperitoneal lymph nodes and/or microscopic metastasis beyond the pelvis. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIA Ovarian Cancer","conceptCode":"C128087","definition":"Ovarian cancer with positive retroperitoneal lymph nodes and/or microscopic metastasis beyond the pelvis. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5BCA-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5BE3-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"FIGO Stage IIIB Ovarian Cancer","ValueMeaning":{"publicId":"5326891","version":"1","preferredName":"FIGO Stage IIIB Ovarian Cancer","longName":"5326891","preferredDefinition":"Ovarian cancer with macroscopic, extrapelvic, peritoneal metastasis equal or less than 2 cm ± positive retroperitoneal lymph nodes. Includes extension to capsule of liver/spleen. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIB Ovarian Cancer","conceptCode":"C128092","definition":"Ovarian cancer with macroscopic, extrapelvic, peritoneal metastasis equal or less than 2 cm +/- positive retroperitoneal lymph nodes. Includes extension to capsule of liver/spleen. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5BEF-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5C08-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"FIGO Stage IIIC Ovarian Cancer","ValueMeaning":{"publicId":"5326892","version":"1","preferredName":"FIGO Stage IIIC Ovarian Cancer","longName":"5326892","preferredDefinition":"Ovarian cancer with macroscopic, extrapelvic, peritoneal metastasis greater than 2 cm ± positive retroperitoneal lymph nodes. Includes extension to capsule of liver/spleen. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIC Ovarian Cancer","conceptCode":"C128093","definition":"Ovarian cancer with macroscopic, extrapelvic, peritoneal metastasis greater than 2 cm +/- positive retroperitoneal lymph nodes. Includes extension to capsule of liver/spleen. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5C14-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5C2D-83B5-E050-BB89AD435454","beginDate":"2012-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"},{"value":"IV","valueDescription":"FIGO Stage IVA Ovarian Cancer","ValueMeaning":{"publicId":"5326893","version":"1","preferredName":"FIGO Stage IVA Ovarian Cancer","longName":"5326893","preferredDefinition":"Ovarian cancer with pleural effusion with positive cytology. (FIGO, 2014)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IVA Ovarian Cancer","conceptCode":"C128094","definition":"Ovarian cancer with pleural effusion with positive cytology. (FIGO, 2014)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-5C37-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3658CD4F-5C4F-83B5-E050-BB89AD435454","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5326875","version":"1","preferredName":"Ovarian Cancer by FIGO Stage Stage","preferredDefinition":"A category of staging terms for ovarian cancer according to the International Federation of Gynecology and Obstetrics (FIGO), 2014. AJCC ovarian cancer stage terms from the 6th and 7th editions that are synonymous to the FIGO ovarian cancer staging classification of 2014 are included as preferred terms:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C128081:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Cancer by FIGO Stage","conceptCode":"C128081","definition":"A category of staging terms for ovarian cancer according to the International Federation of Gynecology and Obstetrics (FIGO), 2014. AJCC ovarian cancer stage terms from the 6th and 7th editions that are synonymous to the FIGO ovarian cancer staging classification of 2014 are included as preferred terms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-59A6-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"ONEDATA","dateModified":"2016-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3658CD4F-59B7-83B5-E050-BB89AD435454","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"COOPERM","dateModified":"2016-06-29","changeDescription":"Created for Duke study in Rave. mc 6/28/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3434441","version":"1","longName":"Ovarian","context":"NCIP"}]},{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736428","version":"1","longName":"Ovary Clinical Data Entry","context":"BBRB"},{"publicId":"6736426","version":"1","longName":"Ovary Local Path Review","context":"BBRB"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"},{"publicId":"10000585","version":"1","longName":"FIGO","context":"NCI Standards"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000168","version":"1","longName":"Ovarian","context":"OCG"},{"publicId":"7026248","version":"1","longName":"Endometrial","context":"OCG"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"FIGO Stage","type":"Preferred Question Text","description":"FIGO Stage","url":null,"context":"NCI Standards"},{"name":"BPV_GTEx 1","type":"BBRB Text","description":"Clinical FIGO Stage","url":null,"context":"BBRB"},{"name":"BPV_GTEx 2","type":"BBRB Text","description":"Pathologic Tumor Stage Grouping (FIGO)","url":null,"context":"BBRB"},{"name":"NRG CRF Text","type":"Alternate Question Text","description":"What is the stage of disease?","url":null,"context":"NRG"}],"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"36592C80-DB0B-BF74-E050-BB89AD433AF2","latestVersionIndicator":"Yes","beginDate":"2016-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-28","modifiedBy":"SARAHB","dateModified":"2022-04-21","changeDescription":"Created for Duke study in Rave. mc 6/28/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}